vancomycin has been researched along with ly-146032 in 81 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 49 (60.49) | 29.6817 |
2010's | 32 (39.51) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Appelbaum, PC; Bhawsar, SB; Bozdogan, B; de Souza, NJ; Desai, VN; Deshpande, PK; Gupte, SV; Hooper, DC; Jacobs, MR; Jha, R; Khorakiwala, HF; Patel, MV; Shetty, N; Shukla, MC; Strahilevitz, J; Yeole, RD | 1 |
Frank, KL; Patel, R; Piper, KE; Reichert, EJ | 1 |
Cheung, CM; Chin, JN; Rybak, MJ; Savage, PB | 1 |
Hsueh, PR; Huang, YT; Liao, CH; Teng, LJ | 1 |
Baltch, AL; Bopp, LH; Michelsen, PB; Ritz, WJ; Smith, RP | 1 |
Alder, JD; Li, T; Mortin, LI; Van Praagh, AD; Zhang, S; Zhang, XX | 1 |
Chaiban, G; Dvorak, T; Hachem, R; Hanna, H; Jiang, Y; Raad, I; Reitzel, R; Sherertz, R | 1 |
Cottagnoud, M; Cottagnoud, P; Schaffner, T; Stucki, A; Winkelmann, V | 1 |
Eliopoulos, GM; Gold, HS; Moellering, RC; Pillai, SK; Sakoulas, G; Wennersten, C | 1 |
Cheung, A; Götz, F; Herbert, S; Meehl, M | 1 |
Jansen, WT; Milatovic, D; Verel, A; Verhoef, J | 1 |
Appelbaum, PC; Bogdanovich, T; Clark, C; Dewasse, B; Kosowska-Shick, K; McGhee, P | 1 |
Alder, JD; Mascio, CT; Silverman, JA | 1 |
Barriere, SL; Benton, BM; Goldberg, MR; Gotfried, MH; Kitt, MM; Krause, KM; Shaw, JP | 1 |
Bayer, AS; Jones, T; Proctor, RA; Sahl, HG; Sakoulas, G; Schrenzel, J; Xiong, YQ; Yang, SJ; Yeaman, MR | 1 |
Cui, L; Hiramatsu, K; Matsuo, M; Neoh, HM; Takeuchi, F; Yuzawa, H | 1 |
Carpenter, CF; Kaatz, GW; Leonard, SN; Rose, WE; Rybak, MJ; Sakoulas, G; Sheth, A; Zervos, MJ | 1 |
Clark, NC; Hageman, J; McDonald, LC; McDougal, LK; Patel, JB; Zhu, W | 1 |
Montero, CI; Murray, PR; Stock, F | 1 |
Fritsche, TR; Jones, RN; Sader, HS | 1 |
Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG | 1 |
Baltch, AL; Bopp, LH; Michelsen, P; Ritz, WJ; Smith, RP | 1 |
Chang, KY; Ho, YH; Hsieh, YC; Hsueh, PR; Huang, LM; Huang, YC; Lin, HC | 1 |
Almela, M; Amat, E; Armero, Y; de la Mària, CG; del Río, A; Gatell, JM; Jiménez de Anta, MT; Marco, F; Mestres, CA; Miró, JM; Moreno, A; Soy, D | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Benton, BM; Draghi, DC; Krause, KM; Pillar, C; Sahm, DF; Thornsberry, C | 1 |
Benton, BM; Debabov, DV; Difuntorum, S; Krause, KM; Renelli, M; Wu, TX | 1 |
Cheung, CM; Leonard, SN; Rybak, MJ | 1 |
Biek, D; Ge, Y; Sahm, DF; Talbot, GH | 1 |
del Pozo, JL; Mandrekar, JN; Patel, R; Rouse, MS; Sampedro, MF; Steckelberg, JM | 1 |
Camargo, IL; Cui, L; Hiramatsu, K; Neoh, HM | 1 |
Arhin, FF; Belley, A; Beveridge, T; Harris, R; McKay, G; Moeck, G; Neesham-Grenon, E; Parr, TR | 1 |
Cui, L; Hiramatsu, K; Neoh, HM; Shoji, M | 1 |
Denis, O; Nguyen, HA; Struelens, MJ; Theunis, A; Tulkens, PM; Van Bambeke, F; Vergison, A | 1 |
Brown, SD; Katz, BD; Steenbergen, JN; Traczewski, MM | 1 |
Daily, SJ; Smeltzer, MS; Spencer, HJ; Weiss, BD; Weiss, EC | 1 |
Bayer, AS; Mishra, NN; Nast, CC; Rubio, A; Sawa, A; Yang, SJ; Yeaman, MR | 1 |
Arhin, FF; Beaulieu, S; McKay, GA; Moeck, G; Parr, TR; Sarmiento, I | 1 |
Jones, RN; Rhomberg, PR; Sader, HS | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Cui, L; Hiramatsu, K; Katayama, Y; Murakami-Kuroda, H | 1 |
Benton, BM; Hartouni, SR; Humphrey, PP; Janc, JW; Lunde, CS; Mammen, M | 1 |
Chen, H; Chen, M; Liu, Y; Ma, Y; Nichols, WW; Sun, W; Wang, H; Zhang, J; Zhao, C | 1 |
Bolanos, M; Finegold, SM; Molitoris, DR; Sumannen, PH | 1 |
Bavari, S; Bowlin, T; Butler, MM; Gussio, R; Houseweart, C; Lane, D; Moir, DT; Nguyen, T; Opperman, T; Panchal, RG; Peet, NP; Ulrich, RL; Williams, JD | 1 |
Ariza, J; Cabellos, C; Cabo, J; Euba, G; Garrigós, C; Gudiol, F; Murillo, O; Pachón, ME; Verdaguer, R | 1 |
Arhin, FF; Draghi, DC; Moeck, G; Parr, TR; Pillar, CM; Sahm, DF | 1 |
Bowker, KE; Caspers, P; Gaucher, B; MacGowan, AP | 1 |
Bonafede, M; Evans, A; Ferro, S; Harrington, S; Lodise, TP; Lubanski, P; Patel, N; Stellrecht, K | 1 |
Basuino, L; Bauer, D; Chambers, HF; Diep, BA; Tattevin, P | 1 |
Alexander, DC; Baltz, RH; Brian, P; Chu, M; Gu, JQ; He, X; Li, C; Mascio, C; Mortin, L; Nguyen, KT; Silverman, JA; Van Praagh, A | 1 |
Betriu, C; Culebras, E; Gómez, M; López-Fabal, F; Morales, G; Picazo, JJ; Rodríguez-Avial, I | 1 |
Janechek, MJ; Jones, RN; Mendes, RE; Moet, GJ | 1 |
Johnson, L; Pawlak, J; Saravolatz, L | 1 |
Almela, M; Armero, Y; Cervera, C; del Río, A; Falces, C; García-de-la-Mària, C; Gatell, JM; Jiménez de Anta, MT; Marco, F; Mestres, CA; Miró, JM; Moreno, A; Ninot, S; Soy, D | 1 |
Bayer, AS; Fey, PD; Mishra, NN; Nast, CC; Yang, SJ; Yeaman, MR | 1 |
Chen, FJ; Huang, IW; Lauderdale, TL; Lee, CH; Wang, MC | 1 |
Cheung, CM; Leuthner, KD; Rybak, MJ; Vidaillac, C | 1 |
Bavari, S; Bowlin, TL; Butler, MM; Moir, DT; Panchal, RG; Peet, NP; Shinabarger, DL; Williams, JD | 1 |
Graninger, W; Hajdu, S; Hirschl, AM; Holinka, J; Presterl, E; Reichmann, S | 1 |
Parra-Ruiz, J; Rose, WE; Rybak, MJ; Vidaillac, C | 1 |
Camargo, IL; Cui, L; Fukuda, M; Hiramatsu, K; Hishinuma, T; Isii, T; Neoh, HM; Ochiai, T; Shoji, M; Watanabe, Y | 1 |
Crandon, JL; Kuti, JL; Nicolau, DP | 1 |
Benadda, S; Chau, F; Dubée, V; Fantin, B; Lefort, A | 1 |
Barnes, MH; Brown, NC; Butler, MM; Dvoskin, S; Gambino, JJ; Long, ZY; Wright, GE; Xu, WC; Zhi, CX | 1 |
Kang, H; Kim, H; Nam, SJ; Rho, BJ; Wang, W | 1 |
Aung, TT; Beuerman, RW; Cao, D; Chan, HS; Dai, X; Koh, JJ; Lakshminarayanan, R; Li, J; Lim, FH; Lin, H; Liu, S; Qiu, S; Saraswathi, P; Tan, AL; Tan, DT; Tang, C; Verma, C; Zhou, L; Zou, H | 1 |
Aung, TT; Bai, Y; Beuerman, RW; Cao, D; Koh, JJ; Koh, WL; Lakshminarayanan, R; Li, J; Lim, F; Lin, H; Lin, S; Liu, S; Pang, LM; Pervushin, K; Qiu, S; Salleh, SM; Tan, DT; Verma, C; Zhou, L; Zou, H | 1 |
Antunes, NT; Boudreau, MA; Chang, M; Ding, D; Lastochkin, E; Leemans, E; Lichtenwalter, K; Mobashery, S; O'Daniel, PI; Peng, Z; Pi, H; Schroeder, VA; Song, W; Spink, E; Suckow, MA; Testero, SA; Vakulenko, S; Wolter, WR | 1 |
Citron, D; He, Y; Herradura, P; Howland, K; Keith, D; Li, J; Mascio, CT; Mesleh, MF; Metcalf, C; Mortin, LI; Pearson, A; Silverman, J; Steenbergen, J; Thorne, GM; Van Praagh, AD; Yin, N | 1 |
Athanassopoulos, CM; Dinos, GP; Garnelis, T; Kalpaxis, DL; Kostopoulou, ON; Kournoutou, GG; Leotsinidis, M; Magoulas, GE; Papaioannou, D | 1 |
Bermudez, C; Butler, MS; Cooper, MA; Edwards, DJ; Elliott, AG; Fraser, JA; Huang, JX; Rees, KA; Ripen, JE; Seta, C; Yeo, TC | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Steenbergen, J; Tanaka, SK; Villano, S | 1 |
Dong, Y; Golla, RM; Lushnikova, T; Wang, G; Wang, X | 1 |
Choi, H; Giri, AG; Hahn, D; Kang, H; Kim, H; Lee, J; Nam, SJ; Patil, RS; Sung, Y; Wang, W; Won, DH | 1 |
Abouelhassan, Y; Garrison, AT; Huigens, RW; Jin, S; Kallifidas, D; Kim, YS; Luesch, H; Tan, H | 1 |
Anne Marie, V; Cai, J; Li, C; Li, Y; Nimmagadda, A; Peng, Z; Su, M; Sun, X; Teng, P | 1 |
Abouelhassan, Y; Basak, A; Huigens, RW; Jin, S; Kim, YS; Norwood, VM | 1 |
Abouelhassan, Y; Garrison, AT; Huigens Iii, RW; Nguyen, TJ; Yang, H; Yousaf, HH | 1 |
Abdeen, S; Ambrose, AJ; Chapman, E; Hoang, QQ; Johnson, SM; Kunkle, T; Park, Y; Ray, AM; Salim, N; Stevens, M; Victorino, J | 1 |
2 review(s) available for vancomycin and ly-146032
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Drug Discovery; Humans; Microbial Sensitivity Tests; Molecular Conformation; Tetracyclines | 2016 |
1 trial(s) available for vancomycin and ly-146032
Article | Year |
---|---|
Intrapulmonary distribution of intravenous telavancin in healthy subjects and effect of pulmonary surfactant on in vitro activities of telavancin and other antibiotics.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Female; Humans; Injections, Intravenous; Lipoglycopeptides; Lung; Macrophages, Alveolar; Male; Methicillin Resistance; Microbial Sensitivity Tests; Pulmonary Surfactants; Staphylococcus aureus; Streptococcus pneumoniae; Treatment Outcome | 2008 |
78 other study(ies) available for vancomycin and ly-146032
Article | Year |
---|---|
A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Clinical Trials, Phase I as Topic; Dogs; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Half-Life; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Mutation; Prodrugs; Quinolizines; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship; Vancomycin Resistance | 2005 |
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biofilms; DNA, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Nafcillin; Oxazolidinones; Penicillin-Binding Proteins; Penicillins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcal Infections; Staphylococcus; Tetracycline | 2007 |
Antimicrobial activities of ceragenins against clinical isolates of resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Microbial Sensitivity Tests; Staphylococcus aureus; Steroids; Vancomycin Resistance | 2007 |
Daptomycin susceptibility of unusual gram-positive bacteria: comparison of results obtained by the Etest and the broth microdilution method.
Topics: Culture Media; Daptomycin; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests | 2007 |
Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Combinations; Gentamicins; Humans; Microbial Sensitivity Tests; Monocytes; Oxacillin; Rifampin; Staphylococcus aureus; Vancomycin | 2007 |
Rapid bactericidal activity of daptomycin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus peritonitis in mice as measured with bioluminescent bacteria.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Daptomycin; Female; Linezolid; Luminescent Measurements; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Neutropenia; Oxazolidinones; Peritonitis; Staphylococcus aureus | 2007 |
Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Biofilms; Catheterization, Central Venous; Daptomycin; Humans; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Staphylococcus aureus; Tigecycline | 2007 |
Daptomycin produces an enhanced bactericidal activity compared to ceftriaxone, measured by [3H]choline release in the cerebrospinal fluid, in experimental meningitis due to a penicillin-resistant pneumococcal strain without lysing its cell wall.
Topics: Animals; Anti-Bacterial Agents; Bacteriolysis; Ceftriaxone; Cell Wall; Cerebrospinal Fluid; Choline; Daptomycin; Disease Models, Animal; Humans; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillin Resistance; Rabbits; Streptococcus pneumoniae; Treatment Outcome; Tritium | 2007 |
Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF.
Topics: Amino Acid Substitution; Aminoacyltransferases; Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; Humans; Microbial Sensitivity Tests; Mutation; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2007 |
Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Polymyxin B; Signal Transduction; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2007 |
In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pyogenes; Vancomycin Resistance; Viridans Streptococci | 2007 |
Antistaphylococcal activity of CG400549, a new experimental FabI inhibitor, compared with that of other agents.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enzyme Inhibitors; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Pyridines; Staphylococcus aureus; Thienopyridines; Thiophenes; Virginiamycin | 2007 |
Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells.
Topics: Anti-Bacterial Agents; Cell Division; Ciprofloxacin; Daptomycin; Erythromycin; Gentamicins; Hydrazones; Microbial Sensitivity Tests; Nafcillin; Staphylococcus aureus; Vancomycin | 2007 |
Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding.
Topics: Anti-Bacterial Agents; Cell Membrane; Cell Membrane Permeability; Daptomycin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Phospholipids; Staphylococcal Infections; Staphylococcus aureus; Treatment Failure | 2008 |
Mutated response regulator graR is responsible for phenotypic conversion of Staphylococcus aureus from heterogeneous vancomycin-intermediate resistance to vancomycin-intermediate resistance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Gene Expression Regulation, Bacterial; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Oligonucleotide Array Sequence Analysis; Phenotype; Sequence Analysis, DNA; Signal Transduction; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2008 |
daptomycin activity against Staphylococcus aureus following vancomycin exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations.
Topics: Anti-Bacterial Agents; Culture Media; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Models, Biological; Staphylococcus aureus; Vancomycin | 2008 |
Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Conjugation, Genetic; DNA Transposable Elements; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Humans; Michigan; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Restriction Mapping; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance | 2008 |
Mechanisms of resistance to daptomycin in Enterococcus faecium.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Leukocyte-Adhesion Deficiency Syndrome; Microbial Sensitivity Tests; Point Mutation; Polymerase Chain Reaction; Vancomycin | 2008 |
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ceftaroline; Cephalosporins; Community-Acquired Infections; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; United States | 2008 |
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance | 2008 |
Activities of daptomycin and comparative antimicrobials, singly and in combination, against extracellular and intracellular Staphylococcus aureus and its stable small-colony variant in human monocyte-derived macrophages and in broth.
Topics: Anti-Bacterial Agents; Cells, Cultured; Daptomycin; Gentamicins; Humans; Macrophages; Microbial Sensitivity Tests; Monocytes; Rifampin; Staphylococcus aureus | 2008 |
Clonal spread of highly beta-lactam-resistant Streptococcus pneumoniae isolates in Taiwan.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Genotype; Humans; Microbial Sensitivity Tests; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; Taiwan | 2008 |
Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Disease Models, Animal; Endocarditis, Bacterial; Glycopeptides; Heart Valve Diseases; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Models, Biological; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Prospective Studies; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae; United States | 2008 |
In vitro activity of telavancin against resistant gram-positive bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Streptococcus | 2008 |
Activities of ceftobiprole, linezolid, vancomycin, and daptomycin against community-associated and hospital-associated methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Daptomycin; Drug Synergism; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; United States | 2008 |
Effect of electrical current on the activities of antimicrobial agents against Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis biofilms.
Topics: Anti-Infective Agents; Biofilms; Bioreactors; Electricity; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Staphylococcus epidermidis | 2009 |
Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; Drug Resistance, Bacterial; Humans; Membrane Fluidity; Membrane Potentials; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Phenotype; Vancomycin | 2008 |
Oritavancin kills stationary-phase and biofilm Staphylococcus aureus cells in vitro.
Topics: Anti-Bacterial Agents; Biofilms; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Glycopeptides; Kinetics; Lipoglycopeptides; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Plankton; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Chromosome Walking; DNA-Binding Proteins; Genetic Engineering; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
Topics: Anti-Bacterial Agents; Cell Line; Cystic Fibrosis; Dose-Response Relationship, Drug; Fusidic Acid; Gentamicins; Humans; Macrophages; Microbial Sensitivity Tests; Oxacillin; Phenotype; Protein Binding; Staphylococcus aureus; Thymidine | 2009 |
Inhibitory and bactericidal activities of daptomycin, vancomycin, and teicoplanin against methicillin-resistant Staphylococcus aureus isolates collected from 1985 to 2007.
Topics: Abscess; Anti-Bacterial Agents; Blood; Culture Media; Daptomycin; Drug Resistance, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Teicoplanin; Vancomycin | 2009 |
Impact of sarA on antibiotic susceptibility of Staphylococcus aureus in a catheter-associated in vitro model of biofilm formation.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Catheterization; Daptomycin; Microbial Sensitivity Tests; Mutation; Staphylococcus aureus; Vancomycin | 2009 |
Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cell Membrane; Daptomycin; Membrane Fluidity; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phenotype; Phospholipids | 2009 |
Impact of human serum albumin on oritavancin in vitro activity against enterococci.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Enterococcus; Glycopeptides; Lipoglycopeptides; Microbial Sensitivity Tests; Protein Binding; Serum Albumin | 2009 |
Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Vancomycin | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
Topics: Anti-Bacterial Agents; beta-Lactams; Blotting, Northern; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Imipenem; Microbial Sensitivity Tests; Mutation; Sequence Analysis, DNA; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Telavancin disrupts the functional integrity of the bacterial membrane through targeted interaction with the cell wall precursor lipid II.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cell Wall; Flow Cytometry; Lipoglycopeptides; Membrane Potentials; Methicillin Resistance; Microbial Sensitivity Tests; Microscopy, Phase-Contrast; Staphylococcus aureus; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin | 2009 |
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
Topics: Anti-Bacterial Agents; China; Cities; Drug Resistance, Multiple, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2009 |
In vitro activities of telavancin and six comparator agents against anaerobic bacterial isolates.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria, Anaerobic; Clostridioides difficile; Gram-Negative Bacteria; Gram-Positive Bacteria; Lipoglycopeptides; Microbial Sensitivity Tests | 2009 |
Novel broad-spectrum bis-(imidazolinylindole) derivatives with potent antibacterial activities against antibiotic-resistant strains.
Topics: Animals; Anti-Bacterial Agents; Bacillus anthracis; Cell Death; Cell Line; Gram-Negative Bacteria; Gram-Positive Bacteria; Macrophages; Mice; Staphylococcus aureus; Yersinia pestis | 2009 |
Efficacy of high doses of daptomycin versus alternative therapies against experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Foreign-Body Reaction; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rats; Rats, Wistar | 2009 |
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Glycopeptides; Gram-Positive Bacteria; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus | 2009 |
In vitro activities of three new dihydrofolate reductase inhibitors against clinical isolates of gram-positive bacteria.
Topics: Folic Acid Antagonists; Gram-Positive Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phthalazines; Staphylococcus aureus; Streptococcus | 2009 |
Correlation between vancomycin MIC values and those of other agents against gram-positive bacteria among patients with bloodstream infections caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cohort Studies; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2009 |
Ceftobiprole is superior to vancomycin, daptomycin, and linezolid for treatment of experimental endocarditis in rabbits caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Cephalosporins; Chromatography, High Pressure Liquid; Daptomycin; Disease Models, Animal; Endocarditis, Bacterial; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Rabbits; Random Allocation; Vancomycin | 2010 |
Genetically engineered lipopeptide antibiotics related to A54145 and daptomycin with improved properties.
Topics: Animals; Anti-Bacterial Agents; Cattle; Daptomycin; Female; Genes, Bacterial; Gram-Positive Bacteria; Lipoproteins; Mice; Microbial Sensitivity Tests; Molecular Structure; Pneumonia, Pneumococcal; Protein Engineering; Pulmonary Surfactants; Staphylococcus aureus; Streptomyces | 2010 |
Comparative activities of TR-700 (torezolid) against staphylococcal blood isolates collected in Spain.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; In Vitro Techniques; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Sepsis; Spain; Staphylococcal Infections; Tetrazoles; Vancomycin | 2010 |
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Linezolid; Lipoglycopeptides; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin | 2010 |
In vitro activity of ceftaroline against community-associated methicillin-resistant, vancomycin-intermediate, vancomycin-resistant, and daptomycin-nonsusceptible Staphylococcus aureus isolates.
Topics: Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2010 |
Daptomycin is effective for treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus epidermidis.
Topics: Animals; Daptomycin; Endocarditis; Glycopeptides; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2010 |
Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanisms.
Topics: Aminoacyltransferases; Anti-Bacterial Agents; Bacterial Proteins; Blood; Cell Wall; Daptomycin; Drug Resistance, Multiple, Bacterial; Endocarditis, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Mutation; Octoxynol; Phenotype; Staphylococcal Infections | 2010 |
Development of daptomycin nonsusceptibility with heterogeneous vancomycin-intermediate resistance and oxacillin susceptibility in methicillin-resistant Staphylococcus aureus during high-dose daptomycin treatment.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oxacillin; Oxazolidinones; Teicoplanin; Vancomycin Resistance | 2010 |
In vitro activity of the new multivalent glycopeptide-cephalosporin antibiotic TD-1792 against vancomycin-nonsusceptible Staphylococcus isolates.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Daptomycin; Glycopeptides; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus; Staphylococcus aureus; Vancomycin; Vancomycin Resistance; Virginiamycin | 2010 |
Comparative in vitro activity profiles of novel bis-indole antibacterials against gram-positive and gram-negative clinical isolates.
Topics: Anti-Bacterial Agents; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Indoles; Microbial Sensitivity Tests | 2010 |
Increased temperature enhances the antimicrobial effects of daptomycin, vancomycin, tigecycline, fosfomycin, and cefamandole on staphylococcal biofilms.
Topics: Anti-Bacterial Agents; Biofilms; Cefamandole; Daptomycin; Fosfomycin; Minocycline; Staphylococcus; Tigecycline; Vancomycin | 2010 |
Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm.
Topics: Anti-Bacterial Agents; Aza Compounds; Biofilms; Clarithromycin; Daptomycin; Fluoroquinolones; Microscopy, Electron, Scanning; Moxifloxacin; Quinolines; Rifampin; Staphylococcus aureus; Vancomycin | 2010 |
An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; Drug Resistance, Multiple, Bacterial; Mutation; Polymorphism, Single Nucleotide; Staphylococcus aureus; Vancomycin | 2010 |
Comparative efficacies of human simulated exposures of telavancin and vancomycin against methicillin-resistant Staphylococcus aureus with a range of vancomycin MICs in a murine pneumonia model.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Disease Models, Animal; Female; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pneumonia; Staphylococcal Infections; Vancomycin | 2010 |
Flow cytometry as a tool to determine the effects of cell wall-active antibiotics on vancomycin-susceptible and -resistant Enterococcus faecalis strains.
Topics: Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Enterococcus faecalis; Flow Cytometry; Lipoglycopeptides; Microscopy, Confocal; Vancomycin | 2011 |
7-Alkyl-N(2)-substituted-3-deazaguanines. Synthesis, DNA polymerase III inhibition and antibacterial activity.
Topics: Animals; Anti-Bacterial Agents; DNA Polymerase III; Enzyme Inhibitors; Escherichia coli; Gram-Positive Bacteria; Guanine; Mice; Microbial Sensitivity Tests; Staphylococcal Infections | 2011 |
Antibacterial butenolides from the Korean tunicate Pseudodistoma antinboja.
Topics: 4-Butyrolactone; Acetamides; Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Linezolid; Marine Biology; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Oxazolidinones; Republic of Korea; Urochordata; Vancomycin | 2012 |
Design and synthesis of amphiphilic xanthone-based, membrane-targeting antimicrobials with improved membrane selectivity.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Cell Membrane; Chemistry Techniques, Synthetic; Drug Design; Hydrophobic and Hydrophilic Interactions; Microbial Sensitivity Tests; Molecular Conformation; Molecular Dynamics Simulation; Rabbits; Substrate Specificity; Xanthones | 2013 |
Amino acid modified xanthone derivatives: novel, highly promising membrane-active antimicrobials for multidrug-resistant Gram-positive bacterial infections.
Topics: Amino Acids; Animals; Anti-Bacterial Agents; Cell Membrane; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacterial Infections; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Rabbits; Structure-Activity Relationship; Unilamellar Liposomes; Xanthones | 2015 |
Structure-activity relationship for the oxadiazole class of antibiotics.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Oxadiazoles; Staphylococcus aureus; Structure-Activity Relationship | 2015 |
Structure-Activity Relationship Studies of a Series of Semisynthetic Lipopeptides Leading to the Discovery of Surotomycin, a Novel Cyclic Lipopeptide Being Developed for the Treatment of Clostridium difficile-Associated Diarrhea.
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Cricetinae; Diarrhea; Enterocolitis, Pseudomembranous; Lipopeptides; Male; Microbial Sensitivity Tests; Peptides, Cyclic; Structure-Activity Relationship | 2015 |
Synthesis and antimicrobial activity of chloramphenicol-polyamine conjugates.
Topics: Acetyltransferases; Anti-Bacterial Agents; Bacterial Proteins; Chloramphenicol; Enzyme Assays; Escherichia coli; Gene Expression; Kinetics; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Phthalic Anhydrides; Spermidine; Succinic Anhydrides | 2015 |
Flemingin-Type Prenylated Chalcones from the Sarawak Rainforest Plant Desmodium congestum.
Topics: Chalcones; Fabaceae; Gram-Positive Bacteria; HEK293 Cells; Humans; Malaysia; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Prenylation; Rainforest | 2015 |
Small molecule mimics of DFTamP1, a database designed anti-Staphylococcal peptide.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Drug Design; Molecular Structure; Peptides; Small Molecule Libraries; Structure-Activity Relationship | 2017 |
Cadiolides J-M, antibacterial polyphenyl butenolides from the Korean tunicate Pseudodistoma antinboja.
Topics: 4-Butyrolactone; Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Republic of Korea; Structure-Activity Relationship; Urochordata | 2017 |
An Efficient Buchwald-Hartwig/Reductive Cyclization for the Scaffold Diversification of Halogenated Phenazines: Potent Antibacterial Targeting, Biofilm Eradication, and Prodrug Exploration.
Topics: Anti-Bacterial Agents; Biofilms; Cyclization; Halogenation; HeLa Cells; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phenazines | 2018 |
Facilely accessible quinoline derivatives as potent antibacterial agents.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Female; Gram-Positive Bacteria; Humans; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Quinolines; Structure-Activity Relationship | 2018 |
Halogenated quinolines bearing polar functionality at the 2-position: Identification of new antibacterial agents with enhanced activity against Staphylococcus epidermidis.
Topics: Anti-Bacterial Agents; Cell Survival; Dose-Response Relationship, Drug; Erythrocytes; Halogenation; HeLa Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Quinolines; Staphylococcus epidermidis; Structure-Activity Relationship | 2018 |
Microwave-enhanced Friedländer synthesis for the rapid assembly of halogenated quinolines with antibacterial and biofilm eradication activities against drug resistant and tolerant bacteria.
Topics: | 2017 |
Hydroxybiphenylamide GroEL/ES Inhibitors Are Potent Antibacterials against Planktonic and Biofilm Forms of Staphylococcus aureus.
Topics: Amides; Anti-Bacterial Agents; Biofilms; Chaperonin 10; Chaperonin 60; HEK293 Cells; Humans; Staphylococcus aureus | 2018 |